EU Medical Device Regulation

EU MDR 2017/745

The European Union's medical device regulation framework.

Knowledge Hub
2017/745
EU Regulation
2021 Full Application
Replaced MDD 93/42
Annex I–IX
Documentation requirements
Notified Body
Required for Class II+
Overview

EU Medical Device Regulation (MDR) 2017/745 governs the manufacture and sale of medical devices in the European Union, replacing the Medical Device Directive (MDD). It significantly increased documentation requirements compared to its predecessor — particularly for clinical evidence, post-market surveillance, and technical documentation.

MDR requires manufacturers to maintain a Technical Documentation file for each device, including a Clinical Evaluation Report (CER) demonstrating clinical safety and performance, Post-Market Clinical Follow-Up (PMCF) plans and reports, Post-Market Surveillance (PMS) plans, and a Summary of Safety and Clinical Performance (SSCP). The documentation burden is substantially higher than under MDD — a significant challenge that has delayed CE marking for many manufacturers.

Standard Identity
EU MDR 2017/745
EU Medical Device Regulation
EU MDR
Key Requirements

What the standard
requires you to document.

Annex I – GSPR

General Safety and Performance Requirements documentation — device risk management aligned with ISO 14971.

Annex II – Technical Documentation

Device description, design documentation, labeling, intended purpose, and clinical evaluation.

Annex III – Clinical Evaluation & PMS

Clinical Evaluation Plan, Clinical Evaluation Report, PMCF plan and report.

Annex XIV – Clinical Investigation

Clinical investigation plan and report documentation if required.

Annex XV – SSCP

Summary of Safety and Clinical Performance for implantable and Class III devices.

UDI Requirements

Unique Device Identification labeling documentation and EUDAMED registration records.

ELDR Documentation

Templates and resources
available from the Knowledge Hub.

Technical Documentation structure aligned with MDR Annex II
Clinical Evaluation Plan (CEP) and Clinical Evaluation Report (CER)
Post-Market Surveillance (PMS) Plan and PMS Report
Post-Market Clinical Follow-Up (PMCF) Plan and Evaluation Report
Summary of Safety and Clinical Performance (SSCP) — Annex XV
Instructions for Use (IFU) — MDR Annex I, Section 23
Risk Management File documentation (ISO 14971:2019)
Periodic Safety Update Report (PSUR) templates
Request Access

Templates and implementation resources for EU MDR 2017/745 are available through the ELDR Institute Knowledge Hub and via direct request.

Or: institute@eldrinc.com

Related Frameworks